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Introduction
Long-term gene expression is an essential part of human gene therapy. To achieve sustained gene expression, there are two distinct approaches. One is the integration of a transgene into the host genome. Insertion of a transgene into the genome of nondividing cells has been problematic. A recent report showed that the new lentivirus vector could target the transgene to the nucleus and stimulate integration into the host genome in nondividing neuronal cells. 1 Although this technique may forward human gene therapy, it is limited by random integration of the transgene into the host chromosomal DNA. Random insertion may induce some pathological changes in tissues such as tumorigenesis, growth inhibition, cell death in tissues, or lead to undesirable activation or inactivation of the transgene. 2, 3 Therefore, site-specific integration is desirable. AAV (adeno-associated virus) vector may be able to be inserted into the AAVS1 region in human cells, 4 but it has not been widely studied, especially in nondividing cells. Another approach is the stable retention of an episomal piece of DNA. The herpes virus group, which induces latent infection, has been shown to retain its genome extrachromosomally in the nucleus of host cells. Epstein-Barr virus (EBV) has been analyzed thoroughly in terms of its latent infection. The cis-acting oriP (the latent viral DNA replication origin) sequence, which contains FR (family of repeat) and DS
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Received 16 December 1997; accepted 11 March 1998 (dyad symmetry), and the trans-acting EBV nuclear antigen-1 (EBNA-1) are required for EBV latent infection, which is characterized by autonomous replication and nuclear retention of the EBV genome in host cells. [5] [6] [7] From the viewpoint of sustained gene expression, a gene delivery vector based on EBV has been constructed. 8 However, this EBV vector can transfer genes to B lymphocytes but not to other somatic cells. Another approach is the co-introduction of the EBNA-1 and oriP sequences, which are the minimum EBV components for the maintenance of a transgene. An EBV replicon vector has been established, and long-term gene expression driven by an EBV replicon vector has been confirmed in mammalian cells. 9 However, with regard to human gene therapy, the methodology for delivery of the replicon plasmid, especially to various tissue cells in vivo, remains to be resolved.
We developed a hybrid vector between liposome and HVJ (Sendai virus) for gene therapy. 10 HVJ liposome can deliver genes efficiently by cell fusion to almost all cells in vivo, and numerous successful results of experimental gene therapy have been reported. 11 However, the main limitation of the vector system is the transient transgene expression.
10,11 Therefore, we attempted to combine HVJ liposomes with an EBV replicon vector for sustained gene expression in mammalian cells. An EBV replicon plasmid containing the luciferase gene was constructed and transferred into various culture cells using HVJ liposomes. The sustained, enhanced luciferase expression was obtained in HeLa-S3, HEK 293, FS 3 and BHK-21 cells. In human cells, a portion of the introduced EBV replicon plasmid was autonomously replicated. When HVJ liposomes including the EBV replicon vector were injected directly into mouse liver, gene expression was maintained for at least 35 days.
Results
Gene expression in cultured mammalian cells by the EBV replicon vector using HVJ-cationic liposomes Luciferase activity was measured in HeLa-S3, HEK 293, FS 3 and BHK-21 cells at various time-points after gene transfer (Figure 1 ). Luciferase gene expression after the introduction of pActLuc was highest on day 1 after the transfer, but then decreased rapidly. However, luciferase activity after the introduction of pEBActLuc was similar to that of pActLuc on day 1 in human cells (HeLa-S3, HEK 293 and FS3 cells), and then increased and was maintained for at least 10 days at levels five to 10 times higher than activity by pActLuc. A similar gene expression pattern was also observed in the human neuroblastoma cell line NB 1 (data not shown). In BHK-21 cells, luciferase gene expression was highest on day 1 and then decreased for both plasmids, but it was maintained on and after day 3 post-transfection for pEBActLuc. Southern blot analysis of the luciferase gene after gene transfer (Figure 2) showed that the plasmid containing the EBV sequence was retained extrachromosomally in the nucleus of BHK-21 cells, while the plasmid DNA with no EBV sequence was lost between days 3 and 9 after transfer. About 100-150 copies of the pEBActLuc were contained in the nucleus on day 9, decreasing between days 9 and 14.
The EBV replicon vector was also useful for obtaining stable transformants. As shown in Table 1 , colonies resistant to G418 were obtained about five to 20 times more efficiently by transfer of the pEBc vector than by transfer of pcDNA3.
Autonomous replication of pEBcLuc in HEK-293 cells It has been reported that EBV can autonomously replicate in primate and canine cells. 12, 13 Therefore, we analyzed the autonomous replication of pEBcLuc in HEK 293 cells. G418-resistant clones of HEK 293 cells were mixed on day 46 after transfer of pEBcLuc or pcLuc. Episomal DNA was digested with BglII or with both BglII and MboI, and subjected to Southern blotting using 32 P-labeled luciferase gene as a probe. As shown in Figure 3 , after BglII digestion, a linear form of each plasmid was detected both in cells transfected with pcLuc and in cells with pEBcLuc. Both pcLuc and pEBcLuc appeared to exist episomally in stable transformants. However, the level of episomal pcLuc was about 15% that of pEBcLuc. The MboI-digested band was only observed in the transfer of pEBcLuc. The ratio of the MboI-sensitive band to the MboI-resistant band was approximately 22%. In FS 3 cells, the episomal pcLuc was about 20% that of pEBcLuc, and the ratio of the MboI-sensitive band to the MboIresistant band was approximately 18%. In HeLa-S3 cells, autonomous replication efficiency was about 35% (data not shown). These results indicate that a portion of pEBcLuc is replicated in human cells, and that pcLuc was not autonomously replicated in human cells.
Sustained in vivo gene expression by EBV replicon vector system HVJ-AVE liposome trapping pEBActLuc or pActLuc was injected directly under the perisplanchnic membrane of a Balb/c mouse liver. Luciferase activity of the liver was assayed at various time-points after the transfer (Figure 4 ). When pActLuc without the EBV sequence was introduced, luciferase gene expression was detected on day 7, but rapidly decreased to insignificant levels by day 14. However, with pEBActLuc, luciferase gene expression also decreased between days 7 and 14, but the expression level remained constant after day 14 for at least 35 days. We injected naked DNA (pActLuc and pEBActLuc) directly into mouse liver. The peak level of luciferase activity in liver was 200-400 times lower with naked DNA than that with HVJ-AVE liposomes (data not shown). This was consistent with our previous finding.
Figure 2 Southern blot of the luciferase gene in BHK-21 cells on days 3 (lanes 1 and 4), 9 (lanes 2 and 5) and 14 (lanes 3 and 6) after the transfer of pActLuc (arrowhead) (lanes 1-3) or pEBActLuc (arrow) (lanes 4-6
14 Luciferase gene expression with naked DNA injection lasted only 3-4 days in mouse liver.
To confirm the localization of transgene expression in mouse liver, pEBAct-NlacF was injected under the perisplanchnic membrane of a C57/BL6 mouse liver using HVJ-AVE liposomes. Both hepatocytes and non-hepatocytes were transfected. When the lacZ-positive hepatocytes were counted after transfer, the transfection efficiency was approximately 35% on day 7, and expression was still observed in about 12% of hepatocytes on day 35 ( Figure 5) .
Thus, the combination of EBV components and HVJ liposomes appears to be a powerful tool for long-term gene expression in vivo.
Discussion
This report shows that the combination of EBV replicon vector with HVJ liposomes resulted in sustained gene expression in nonlymphocytic cultured cells and mouse liver which are resistant to EBV infection. Because HVJ liposomes can deliver genes (less than 100 kbp) to many other tissues including kidney, artery, lung, brain, heart, skin, muscle, eye and articular cartilage, 11 long-term gene expression can be induced with high efficiency in those tissues by using the EBV replicon vector. This combined gene transfer system will, in the future, be a powerful tool for human gene therapy.
There are several advantages of EBV replicon vectors. One is the autonomous replication of the plasmid in primate and canine cells. 12, 13 However, as shown in Figure  4 , the efficiency of EBV plasmid replication in human cells was not as high, and the level of the unreplicated form was about five times higher than the replicated form. It has been reported that the EBV replicon vector cannot replicate in rodent cells. 12, 13 After the transfer of pEBActLuc, luciferase activity in BHK-21 cells was lower, on and after day 2 than on day 1, while the activity gradually increased in human cells during the same period (Figure 1 ). This also suggests that autonomous replication of EBV plasmid did not occur in BHK-21 cells. However, despite the loss of plasmid replication in BHK-21 cells, luciferase expression was two to seven times higher with pEBActLuc than with pActLuc. A similar gene expression pattern was also detected in other rodent cell lines including mouse fibroblast L and rat pheochro-mocytoma PC-12 (data not shown). As shown by Southern blotting (Figure 2) , pEBActLuc was stably retained in the nuclei of BHK-21 cells but pActLuc was not detected. Nuclear retention of the transgene is the second advantage of the EBV replicon vector. 15 Nuclear retention appears to be mediated by the association of the oriP sequence with the nuclear matrix. 16 On day 3, the number of pEBActLuc copies appeared to be comparable with that of pAct-Luc (Figure 2) . However, on day 3, luciferase expression by pEBActLuc was about twice as high as that by pAct-Luc (Figure 1c) . This may be due to enhanced transcription of oriP-containing DNA by EBNA-1.
17, 18 The activation of viral gene transcription by EBNA-1 is the third advantage of the EBV replicon vector. Thus, high expression of a transgene in an EBV replicon vector in rodent cells may be mediated both by nuclear retention of the gene and by transcription activation. The insertion of a large fragment of human DNA into the EBV replicon vector facilitated the replication of the vector in rodent cells. 12, 13 Although our results in long-term gene expression in BHK-21 cells (Figures 1 and 2 ) indicated that the EBV plasmid could be retained in the nucleus without autonomous replication, the transgene tends to be lost between days 9 and 14 in dividing rodent cells, as shown in Figure 2 . This result suggests that other sequences should be inserted into the vector to stabilize the plasmid in BHK-21 cells. However, gene expression derived from the EBV replicon vector was sustained for much longer in mouse liver (Figures 4 and 5) . It is likely that the EBV replicon vector without human DNA is much more stable in nondividing rodent cells compared with dividing rodent cells, presumably due to the ability of the nuclear retention.
One problem of EBV replicon vector plasmids is an unequal delivery of plasmid copies to daughter cells after cell division. 13 Actually, EBV replicon plasmid disappears from rapidly dividing cells in approximately 2 months in the absence of selection. 19 To solve this problem, the addition of centromeric sequences to the plasmid will be helpful. This work may overlap with the construction of a mammalian artificial chromosome vector. Human artificial microchromosomes are formed by combining alpha satellite DNA with telomeric DNA and genomic DNA, which are mitotically and cytogenetically stable in human HT 1080 cells. 19 Although the mammalian artificial chromosome may be an ideal tool for the retention of a genome of interest, it will be hard to deliver such a large-sized genome to the cytoplasm and to target it to the nucleus. 20, 21 Another problem of an EBV replicon vector is the oncogenicity of EBNA-1 protein. Indeed, transgenic mice harboring the EBNA-1 gene driven by B lymphocytespecific enhancer generated lymphoma. However, several reports have indicated that EB virus proteins, except EBNA-1, were essential for B lymphocyte transformation. [22] [23] [24] [25] [26] We isolated EBNA-1 stable transformants in HEK-293 cells. Those transformants did not grow in softagar plates and were sensitive to serum depletion (Kaneda Y, unpublished observation) . No pathological changes were found in mouse liver transfected with the EBV replicon vector by HVJ liposomes. Gene transfer to lymphocytes by HVJ liposomes was extremely inefficient. 27 Therefore, the coupling of the EBV replicon vector with HVJ liposomes appears to be a safe and efficient gene transfer vector system in human gene therapy.
With respect to sustained gene expression in dividing cells, we prefer integration of the transgene into the host genome to episomal retention of the gene, although integration should be site-specific in the host chromosome. Therefore, the EBV replicon vector may be beneficial for sustained gene expression in nondividing cells. Indeed, gene expression in mouse liver was sustained for at least 35 days as shown in Figures 4 and 5 . This long-term gene expression has not been achieved in the liver of adult animals 11 by a single injection of HVJ liposome containing conventional plasmids. Moreover, naked DNA injection into liver was not successful in efficient gene expression as described in Results. Therefore, HVJ liposome is indispensable for efficient gene delivery and sustained gene expression of the EBV replicon vector system in liver.
Besides sustained gene expression in mouse liver, we recently detected luciferase gene expression in mouse muscles more than 4 months after the transfer of pEBcLuc (Kaneda Y, unpublished data). Thus, the EBV replicon vector combined with HVJ liposomes should result in long-term gene expression in other organs including brain, kidney, lung, cartilage, heart, eye, artery, skin and muscle where HVJ liposome gene delivery has been successful.
Materials and methods

Preparation of EBV replicon vector
The ClaI-NarI fragment of p205 12 (a kind gift from Dr B Sugden, University of Wisconsin, WI, USA) which contains the oriP and triplet repeat (717 bp)-deleted EBNA-1 sequences was isolated and pEBc vector was constructed by cloning the fragment into the BglII site of pcDNA3 (Invitrogen, San Diego, CA, USA) by blunt-end ligation. It has already been reported that this truncated EBNA-1 gave the most efficient replication of oriP-containing DNA. 12 Another EBV replicon vector, pEBAct, was constructed by replacing the CMV promotor of pEBc with the chicken ␤-actin promotor derived from pAct-CAT. 28 Luciferase gene was isolated from pGL2 promotor vector (Promega, Madison, WI, USA) by HindIII and BamHI digestion. pEBcLuc and pEBActLuc were constructed by cloning the DNA at the HindIII and BamHI sites of pEBc and pEBAct, respectively. pcLuc and pActLuc were constructed by cloning the luciferase gene at the HindIII and BamHI sites of pcDNA3 and pAct-CAT, respectively. pEBActNlacF was constructed as follows. NlacF containing the SV40 nuclear transport signal at the N-terminus of the lacZ gene, which was derived from pNlacF 29 (kindly provided by Dr R Palmiter, University of Washington, Seattle, WA, USA), was isolated and then cloned into the pEBAct vector.
Lipids Cholesterol (Chol), egg yolk phosphatidylcholine (ePC), egg yolk sphingomyelin (eSph) and bovine brain sphingomyelin (bSph) were purchased from Sigma (St Louis, MO, USA). Bovine brain phosphatidylserine (bPS) was purchased from Avanti Polar Lipids (Birmingham, AL, USA). Dioleoylphosphatidylethanolamine (DOPE) was obtained from NOF Corporation (Tsukuba, Ibaraki, Japan). DC-cholesterol (DC-Chol) was synthesized as previously reported.
Preparation of HVJ HVJ (Z strain) was grown in chorioallantoic fluid of 10-day-old embryonated chicken eggs at 35.5°C. 27 HVJ was collected as a pellet by centrifugation at 27 000 g for 30 min and was suspended with BSS. HVJ was purified by another centrifugation at 27 000 g for 30 min, resuspended with BSS, and stored at 4°C until use. RNA genome of HVJ was inactivated by ultraviolet irradiation (198 mJ/cm 2 ) immediately before use.
Preparation of liposomes
Each lipid was dissolved in chloroform at a concentration of 30 mm.
14 For the preparation of HVJ-cationic liposome, ePC, Chol and DC-Chol were mixed 45.2:45.9:8.9 in a molar ratio. For HVJ-AVE liposome, ePC, DOPE, eSph, bPS and Chol were mixed 16.7:16.7:16.7:10:50 in a molar ratio. Five hundred microliters of each lipid mixture was transferred into a glass tube and dried as a thin lipid film by evaporation. The dried lipid mixture was hydrated in 200 l of BSS containing plasmid DNA (200 g), which was entrapped by dispersion in the aqueous phase at 37°C. The mixture was agitated intensely by vortexing for 30 s and then left to stand for 30 s. This procedure was repeated eight times. To the tube 800 l of BSS was added, the liposomes suspension was extruded through a cellulose acetate membrane filter (pore size 0.45 m) and the liposomes left in the filter were collected by extruding 500 l of BSS. The 1.5 ml of liposome solution and then 500 l of BSS were extruded through another membrane filter with 0.20 m pores to obtain sized unilamellar liposomes (2 ml in total).
Preparation of HVJ liposomes
The liposome suspension prepared above (2 ml, composed of 15 mol of lipid) was mixed with 1 ml of HVJ suspension (30 000 hemagglutinating units (HAU)) and incubated at 37°C for 2 h with shaking (120 per min) in a water bath. The HVJ liposome complexes were then separated from free HVJ by sucrose density gradient centrifugation. The mixture was layered on to a discontinuous sucrose gradient (1 ml of 50% and 6.5 ml of 30% sucrose in BSS) and centrifuged at 62 800 g at 4°C for 2 h in a swing-bucket rotor. Then the HVJ liposomes were visualized in a layer between BSS and 30% sucrose solution, and free HVJ was sedimented in a layer between 30 and 50% sucrose solution. We collected HVJ liposomes into a sterilized tube using a Pasteur Pipet. The volume of HVJ liposomes was usually about 0.5 ml, and the total volume was adjusted to 1 ml with BSS. 14 
In vitro and in vivo transfection
Cells (human embryonic kidney cells (HEK-293), human cervical carcinoma cells (HeLa-S3), human foreskin normal fibroblasts (FS 3), baby hamster kidney cells (BHK-21)) were purchased from American Type Culture Collection (Rockville, MD, USA). One day before transfection, 2 × 10 5 cells were inoculated into a 100-mm dish. One hundred microliters of 1 ml HVJ-cationic liposome suspension were added to one dish in the presence of Dulbecco's modified minimum essential medium (DMEM) supplemented with 10% fetal calf serum (FCS), incubated with cells for 1 h at 37°C, and then removed. Cells were cultured in 10% FCS-DMEM and harvested at various time-points. To obtain stable transformants, human cells were cultured for 3 weeks after the transfer in the presence of G418 (Geneticin; Gibco BRL, Tokyo, Japan) (500 g/ml for HeLa-S3 cells and 200 g/ml for HEK-293 and FS 3 cells), fixed with 80% methanol, and stained by 1% Giemsa in phosphate-buffered saline (PBS; 137 mm NaCl, 3 mm KCl, 8 mm Na 2 HPO 4 , 1 mm KH 2 PO 4 ).
For in vivo transfection, 8-week-old male Balb/c mice were anesthetized by ether inhalation and handled in a humane fashion in accordance with the guidelines of the Animal Committee of Osaka University. The abdomen was opened with a middle-line incision, and a large lobe of the liver was exposed. Two hundred microliters of HVJ-AVE liposome in 1 ml buffered salt solution (BSS; 10 mm Tris-Cl pH 7.5, 137 mm NaCl and 5.4 mm KCl) with 1 mm CaCl 2 were injected into a lobe of the liver under the perisplanchnic membrane using a 1-ml syringe with a 26-gauge needle, and the incision was sutured. Mice were killed on days 2, 7, 14, 21, 28 and 35 after transfection.
Luciferase assay
Luciferase activity of cultured cells and mouse liver was measured as described elsewhere.
14 At each point, two dishes of cells or two mice were used for each luciferase assay. We repeated the experiments at least three times.
X-gal staining of the liver sections Mice were deeply anesthetized by intraperitoneal injection of diluted pentobarbital (1 mg), perfused with cold-PBS containing 0.1% heparin, and fixed with 1% glutaraldehyde. Liver was isolated and immersed in cold PBS containing 20% sucrose overnight. Sections (10 m) were cut with a cryostat (Miles-Sankyo, Kanagawa, Japan). The sections were stained with 2% X-gal at 37°C overnight as described previously. 31 Southern blot analysis Total genomic DNA of BHK-21 cells was extracted using a DNA extraction kit (Stratagene, La Jolla, CA, USA) on days 3, 9 and 14 after the transfer, and suspended in 100 l TE (10 mm Tris-Cl, 1 mm EDTA, pH 8). One-tenth of the total DNA from each sample was subjected to Southern analysis using 32 P-labeled luciferase gene. HEK 293, Hela-S3 and FS 3 cells were cultured for 30-46 days in 10% FCS-DMEM with G418 after the transfer of pcLuc or pEBcLuc. G418-resistant colonies were mixed in each transfer group, and episomal DNA was isolated from an equal number of cells according to the method described previously. 32 One-tenth of the DNA was digested with BglII or with both BglII and MboI, and subjected to Southern blotting as described above.
